Thailand and Indonesia plan to develop molnupiravir COVID-19 pill
Topics: THAILAND INDONESIA
The molnupiravir COVID-19 treatment pill for adult patients at risk of developing severe illness was jointly developed by Merck and Ridgeback Biotherapeutics.
The Southeast Asian nation intends to join other countries in the region also planning to make versions of the drug including Bangladesh and India.
“For molnupiravir, the Government Pharmaceutical Organization has plans to co-develop (this drug) with the Chulabhorn Research Institute,” Minister Anutin Charnvirakul told a news conference.
“A committee will research and produce the reactants, which will be additional support for future events,” he said.
Separately, Indonesia’s health minister Budi Gunadi Sadikin said on Friday the country also planned to develop molnupiravir in partnership with pharmaceutical company PT. Amarox Pharma Global starting in April or May. ■